DMKJ
EIGR

David M. Knott Jr’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

David M. Knott Jr’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,643
Closed -$3.08M – 187
2022
Q3 		$3.08M Hold
13,643
– – 1.3% 15
2022
Q2 		$2.58M Buy
13,643
+667
+5% +$134K 1.08% 23
2022
Q1 		$3.23M Buy
12,976
+2,393
+23% +$378K 1.03% 29
2021
Q4 		$1.65M Buy
+10,583
New +$2.05M 0.56% 44

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

David M. Knott Jr's EIGR Position: Q4 2022 in Review

David M. Knott Jr sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q4 2022, closing a stake of 13,643 shares — an estimated $3.08M sold.

David M. Knott Jr first reported a position in EIGR in Q4 2021 and held it in 4 quarters. The position peaked at $3.23M in Q1 2022. 81 funds tracked by Wall St. Rank hold EIGR as of Q4 2022.

  • David M. Knott Jr reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • David M. Knott Jr sold 13,643 Eiger BioPharmaceuticals, Inc. shares in Q4 2022, an estimated $3.08M.
  • David M. Knott Jr first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2021 and held it in 4 quarters.
  • David M. Knott Jr's Eiger BioPharmaceuticals, Inc. position peaked at $3.23M in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2022.

Based on David M. Knott Jr's 13F filing for Q4 2022, filed 13 Feb 2023.